|
|
| Research article summary (published 30 May 2006): |
|
Free Full Text! See links below |
Preparing for preventive clinical trials: the Predict-HD study.
Full Abstract
BACKGROUND:
The optimal design and outcome measures for preventive clinical trials in neurodegenerative diseases are unknown.
OBJECTIVE:
To examine measures that may be associated with disease in the largest cohort ever recruited of prediagnosed individuals carrying the gene expansion for Huntington disease (HD).
DESIGN:
The Predict-HD study is a multicenter observational research study in progress at 17 sites in the United States, 4 in Canada, and 3 in Australia.
SETTING:
Genetics and HD outpatient clinics.
PARTICIPANTS:
Five hundred five at-risk individuals who had previously undergone elective DNA analyses for the CAG expansion in the HD gene (predictive testing) and did not currently have a clinical diagnosis of HD.
MAIN OUTCOME MEASURES:
Basal ganglia volumes on magnetic resonance images, estimated probability of diagnosis (based on CAG repeat length), performances on 21 standardized cognitive tasks, total scores on 3 scales of psychiatric distress, and motor diagnosis based on the Unified Huntington's Disease Rating Scale.
RESULTS:
Several variables showed progressive decline as the diagnostic ratings advanced toward manifest disease. Estimated probability of diagnosis was associated with Unified Huntington's Disease Rating Scale prediagnostic stages and varied from 15% in persons with no motor abnormalities to nearly 40% in those with abnormalities suggestive of probable disease. Striatal volumes, cognitive performances, and even psychiatric ratings declined significantly with motor manifestations of disease.
CONCLUSIONS:
The documentation of biological and refined clinical markers suggests several clinical end points for preventive clinical trials. Longitudinal study is critical to further validate possible markers for prediagnosed HD.
Learn Faster Today Improve your study skills
Author information
Author/s: Paulsen, Jane S (JS); Hayden, Michael (M); Stout, Julie C (JC); Langbehn, Douglas R (DR); Aylward, Elizabeth (E); Ross, Christopher A (CA); Guttman, Mark (M); Nance, Martha (M); Kieburtz, Karl (K); Oakes, David (D); Shoulson, Ira (I); Kayson, Elise (E); Johnson, Shannon (S); Penziner, Elizabeth (E); Predict-HD Investigators of the Huntington Study Group;
Affiliation: Department of Psychiatry, University of Iowa, Iowa City 52242-1000, USA. jane-paulsen(-atsign-)uiowa.edu
Grants: 00059 (Agency:PHS HHS) ; 01579 (Agency:PHS HHS) ; 16375 (Agency:PHS HHS) ; 40068 (Agency:PHS HHS)
Journal and publication information
Publication Type: Comparative Study; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal: Archives of neurology (Arch Neurol), published in United States. (Language: eng)
Reference: 2006-Jun; vol 63 (issue 6) : pp 883-90
Dates: Created 2006/06/13; Completed 2006/07/26; Revised 2007/11/14;
PMID: 16769871, status: MEDLINE (last retrieval date: 12/26/2008)
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article (including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MESH Headings shown below.
|
|
Related articles
These are the highest related articles currently in the database:
- Regional cortical thinning in preclinical Huntington disease and its relationship to cognition.
11 Sep 2005 - Longitudinal analysis of regional grey matter loss in Huntington disease: effects of the length of the expanded CAG repeat.
3 Jul 2007 - Psychiatric symptoms do not correlate with cognitive decline, motor symptoms, or CAG repeat length in Huntington's disease.
30 May 1996 - Italian Huntington disease patients--data and tissue bank.
29 Sep 2003 - Brain structure in preclinical Huntington's disease.
20 Aug 2005 - Motor changes in presymptomatic Huntington disease gene carriers.
30 May 1996 - Intrafamilial heterogeneity of facial hyperkinesias: chance association of tics, cranial dystonia, and Huntington's disease?
27 Feb 2001 - Behavioural complaints in participants who underwent predictive testing for Huntington's disease.
30 Oct 2002 - A four-year prospective study of cognitive functioning in Huntington's disease.
29 Jun 2006 - Longitudinal evaluation of "presymptomatic" carriers of Huntington's disease.
30 Dec 2006
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a large map of 100+ related articles.